An assessment of sedative effect of mandrax based on the observation of sleep and urinary catecholamines.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001835:Body Weight; D002395:Catecholamines / Q000652:urine; D004155:Diphenhydramine / Q000494:pharmacology*; D004837:Epinephrine / Q000652:urine; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008702:Methaqualone / Q000494:pharmacology*; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010919:Placebos; D011292:Premedication; D012890:Sleep / Q000187:drug effects*; D013997:Time Factors
D002395:Catecholamines; D006993:Hypnotics and Sedatives; D010919:Placebos; D008702:Methaqualone; D004155:Diphenhydramine; D009638:Norepinephrine; D004837:Epinephrine